Banco Santander’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $32.1M | Buy |
51,479
+10,889
| +27% | +$7.41M | 0.2% | 79 |
|
|
2026
Q1 | $31.4M | Buy |
40,590
+2,858
| +8% | +$2.19M | 0.25% | 65 |
|
|
2025
Q4 | $29.1M | Sell |
37,732
-33,403
| -47% | -$22.7M | 0.22% | 77 |
|
|
2025
Q3 | $40M | Buy |
71,135
+51,577
| +264% | +$29.2M | 0.36% | 43 |
|
|
2025
Q2 | $10.3M | Buy |
19,558
+7,706
| +65% | +$4.3M | 0.1% | 135 |
|
|
2025
Q1 | $7.52M | Buy |
11,852
+4,374
| +58% | +$3.01M | 0.08% | 152 |
|
|
2024
Q4 | $5.33M | Sell |
7,478
-220
| -3% | -$185K | 0.06% | 167 |
|
|
2024
Q3 | $8.09M | Buy |
7,698
+127
| +2% | +$141K | 0.1% | 147 |
|
|
2024
Q2 | $7.96M | Buy |
7,571
+126
| +2% | +$122K | 0.1% | 142 |
|
|
2024
Q1 | $7.17M | Sell |
7,445
-959
| -11% | -$912K | 0.09% | 146 |
|
|
2023
Q4 | $7.38M | Sell |
8,404
-677
| -7% | -$558K | 0.09% | 140 |
|
|
2023
Q3 | $7.47M | Sell |
9,081
-450
| -5% | -$354K | 0.11% | 128 |
|
|
2023
Q2 | $6.85M | Sell |
9,531
-2,070
| -18% | -$1.6M | 0.09% | 137 |
|
|
2023
Q1 | $9.53M | Sell |
11,601
-1,089
| -9% | -$821K | 0.14% | 82 |
|
|
2022
Q4 | $9.16M | Sell |
12,690
-4,084
| -24% | -$3.01M | 0.14% | 92 |
|
|
2022
Q3 | $11.6M | Sell |
16,774
-96
| -0.6% | -$60.4K | 0.15% | 76 |
|
|
2022
Q2 | $9.97M | Sell |
16,870
-3,900
| -19% | -$2.54M | 0.13% | 91 |
|
|
2022
Q1 | $14.5M | Buy |
20,770
+2,370
| +13% | +$1.5M | 0.16% | 86 |
|
|
2021
Q4 | $11.6M | Buy |
18,400
+2,514
| +16% | +$1.55M | 0.06% | 98 |
|
|
2021
Q3 | $9.61M | Sell |
15,886
-2,791
| -15% | -$1.73M | 0.05% | 112 |
|
|
2021
Q2 | $10.4M | Buy |
18,677
+727
| +4% | +$368K | 0.06% | 98 |
|
|
2021
Q1 | $8.49M | Buy |
17,950
+5,063
| +39% | +$2.47M | 0.06% | 103 |
|
|
2020
Q4 | $6.23M | Buy |
12,887
+2,378
| +23% | +$1.28M | 0.04% | 124 |
|
|
2020
Q3 | $5.88M | Buy |
10,509
+2,593
| +33% | +$1.57M | 0.08% | 103 |
|
|
2020
Q2 | $4.94M | Buy |
7,916
+2
| +0% | +$1.14K | 0.06% | 102 |
|
|
2020
Q1 | $3.86M | Buy |
7,914
+514
| +7% | +$212K | 0.04% | 161 |
|
|
2019
Q4 | $2.78M | Buy |
7,400
+50
| +0.7% | +$16.8K | 0.03% | 183 |
|
|
2019
Q3 | $2.05M | Sell |
7,350
-2,700
| -27% | -$799K | 0.02% | 195 |
|
|
2019
Q2 | $3.13M | Buy |
10,050
+3,350
| +50% | +$1.12M | 0.03% | 175 |
|
|
2019
Q1 | $2.72M | Buy |
6,700
+2,000
| +43% | +$824K | 0.03% | 170 |
|
|
2018
Q4 | $1.75M | Hold |
4,700
| – | – | 0.02% | 204 |
|
|
2018
Q3 | $1.9M | Sell |
4,700
-12,100
| -72% | -$4.61M | 0.02% | 203 |
|
|
2018
Q2 | $5.8M | Buy |
+16,800
| New | +$5.25M | 0.07% | 140 |
|
Other funds holding REGN
Banco Santander's REGN Position: Q2 2026 in Review
Banco Santander increased its Regeneron Pharmaceuticals (REGN) stake by 27% in Q2 2026, buying an estimated $7.41M and bringing the position to 51,479 shares worth $32.1M. The position accounts for 0.2% of the portfolio, ranked #79.
Banco Santander first reported a position in REGN in Q2 2018 and has held it in 33 quarters since. The position peaked at $40M in Q3 2025. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Banco Santander held 51,479 shares of Regeneron Pharmaceuticals worth $32.1M as of Q2 2026.
- Banco Santander bought 10,889 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $7.41M.
- Regeneron Pharmaceuticals made up 0.2% of Banco Santander's portfolio in Q2 2026, its #79 holding.
- Banco Santander first reported a position in Regeneron Pharmaceuticals in Q2 2018 and has held it in 33 quarters since.
- Banco Santander's Regeneron Pharmaceuticals position peaked at $40M in Q3 2025.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Banco Santander's 13F filing for Q2 2026, filed 29 Jul 2026.